Literature DB >> 305451

Lymphocyte isolation from chronically inflamed synovial membranes.

G J Lafeber, L B Van de Putte, C J Meijer.   

Abstract

A simple two-step procedure was developed for isolation of lymphocytes from chronically inflamed human synovial membranes. In the first step minced inflamed synovial tissues are disrupted enzymatically by deoxyribonuclease and collagenase. The second step consists of nylon-wool column filtration of the isolated cells. 7 min of preincubation of up to 37.4 X 10(6) cells in a column packed with 600 mg nylon-wool in 6 ml prior to filtration did not result in significant selective losses of either T or B cells, whereas 45 min of preincubation did. Recovery of lymphocytes after nylon-wool column filtration ranged from 68 to 95% (mean 80%) and viability was always higher than 90%. Nylon-wool column filtration increased the proportion of lymphocytes by a mean 73%. The method allows rapid identification of synovial tissue lymphocyte subpopulations as well as characterization of their function.

Entities:  

Mesh:

Year:  1978        PMID: 305451     DOI: 10.1016/0022-1759(78)90020-0

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  3 in total

1.  Human rheumatoid synovial and normal blood dendritic cells as antigen presenting cell--comparison with autologous monocytes.

Authors:  K Waalen; O Førre; J Teigland; J B Natvig
Journal:  Clin Exp Immunol       Date:  1987-10       Impact factor: 4.330

2.  Membrane and transformation characteristics of lymphocytes isolated from the synovial membrane and paired peripheral blood of patients with rheumatoid arthritis.

Authors:  C J Meijer; L B van de Putte; G J Lafeber; E de Haas; A Cats
Journal:  Ann Rheum Dis       Date:  1980-02       Impact factor: 19.103

3.  Eluted rheumatoid synovial tissue T cell subsets and HLA-DR bearing cells at different stages of fractionation.

Authors:  T Egeland; O Førre
Journal:  Clin Rheumatol       Date:  1983-03       Impact factor: 2.980

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.